Vitamina D e Melanoma

João Maia Silva; Catarina de Sousa Teixeira; Miguel Correia

doi:10.29021/spdv.75.1.716

João Maia Silva Dermatologista/Consultant of Dermatology; Clinica Universitária de Dermatologia, Faculdade de Medicina de Lisboa, Universidade de Lisboa; Centro de Dermatologia, Hospital CUF Descobertas, Lisboa, Portugal
Catarina de Sousa Teixeira Interna do Ano Comum de Dermatologia e Venereologia/Resident of the 1st year of Dermatology
Miguel Correia Dermatologista/Consultant of Dermatology; Centro de Dermatologia, Hospital CUF Descobertas, Lisboa, Portugal

DOI: https://doi.org/10.29021/spdv.75.1.716

Keywords: Melanoma, Skin Neoplasms, Sunlight, Vitamin D.

Abstract

Vitamin D plays an important role in calcium homeostasis and bone metabolism. Recently, vitamin D was shown to play an important part in cancer pathology and, more specifically, in melanoma. Seric deficiency of 25(OD)D3, active precursor of vitamin D, has been linked to higher incidence and poorer melanoma prognosis. In vitro studies of several tumors showed that vitamin D supplementation has anti-inflammatory and pro-apoptotic properties, induces differentiation, inhibits proliferation and sensitizes tumoral cells to anti-tumoral therapies. Also, the modulation of the expression of vitamin D receptors (VSR) seems to be implied on vitamin D anti-tumoral effect. The relationship between vitamin D and melanoma becomes more controversial when vitamin D synthesis through UV radiation is associated with increased melanoma risk. In this article we review present bibliography and present clinical suggestions concerning solar exposure, seric blood levels of vitamin D and reduction of melanoma incidence and prognosis.

Downloads

Download data is not yet available.

References

Sondak VK, McIver B, Kanetsky PA. Vitamin D and Melanoma:

What Do We Tell Our Patients? J Clin Oncol.

; 34:1713-14.

Bade B, Zdebik A, Wagenpfeil S, Stefan Gräber, Geisel

J, Vogt T, Reichrath J. Low serum 25-hydroxyvitamin D

concentrations are associated with increased risk for melanoma

and unfa-vourable prognosis. PLoS One. 2014;

: e112863.

Burns EM, Elmets CA, Yusuf N. Vitamin D and skin cancer.

Photochem Photobiol. 2015; 91:201-9.

Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin

D in cutaneous carcinogenesis: part I. J Am Acad

Dermatol 2012; 67:803.

Bikle DD, Nemanic MK, Gee E, Elias P. 1,25-Dihydroxyvitamin

D3 production by human keratinocytes. Kinetics

and regulation. J Clin Investig. 1986; 78:557-66.

Bikle DD, Nemanic MK, Whitney JO, Elias PW. Neonatal

human foreskin keratinocytes produce 1,25-dihydroxyvitamin

D3. Biochemistry. 1986; 25:1545-8.

Fawzi MM, Mahmoud SB, Ahmed SF, Shaker OG. Assessment

of vitamin D receptors in alope-cia areata

and androgenetic alopecia. J Cosmet Dermatol. 2016;

:318-23.

Binkley N, Novotny R, Krueger D, Kawahara T, Daida

YG, Lensmeyer G, et al. Low vitamin D status despite

abundant sun exposure. J Clin Endocrinol Metab. 2007;

:2130-5.

IARC Working Group Reports. Vitamin D and cancer.

[accessed May 2016]. Available from: https://www.

iarc.fr/en/publications/pdfs-online/wrk/wrk5/Report_

VitD.pdf10.

Schuster I. Cytochromes P450 are essential players in

the vitamin D signaling system. Biochim Biophys Acta.

;1814:186-99.

Trochoutsou AI, Kloukina V, Samitas K, Xanthou G. Vitamin-

D in the Immune System: Ge-nomic and Non-Genomic

Actions. Mini Rev Med Chem. 2015; 15:953-63.

Cranney A, Weiler HA, O’Donnell S, Puil L. Summary

of evidence-based review on vitamin D ef-ficacy and

safety in relation to bone health. Am J Clin Nutr. 2008;

:513S-9S.

Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin

physiology: A D-lightful story. J Bone Miner Res. 2007; 22

(Suppl 2);V28-V33.

Winston WT. Malignant Melanoma. Medscape 2016. [accessed

May 2016]. Available from: http://emedicine.medscape.

com/article/280245-overview

Matos D, Alves J, António AM, Bártolo E. Melanoma maligno:

análise retrospetiva 2006-2013. Rev Soc Port Dermatol

Venereol. 2015; 71: 321-28.

Berwick M, Erdei O. Vitamin D and melanoma incidence

and mortality. Pigment Cell Melanoma Res. 2013; 26:9-

D’Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. UV Radiation

and the Skin. Int J Mol Sci. 2013; 14: 12222-48.

Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O,

Picconi O, Boyle P, et al. Meta-analysis of risk factors for

cutaneous melanoma: II. Sun exposure. Eur J Cancer.

; 41:45-60.

Chakraborti C. Vitamin D as a promising anticancer

agent. Indian J Pharmacol. 2011; 43:113-20.

Field S, Newton-Bishop JA. Melanoma and vitamin D.

Mol Oncol. 2011; 5:197-214.

Osborne, JE, Hutchinson PE. Vitamin D and systemic cancer:

Is this relevant to malignant mela-noma? Br J Dermatol.

; 147:197-213.

Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A.

Vitamin D metabolism and action. Osteoporos Int. 1998;

Suppl 2:S13-9.23.

Tang JY, Fu T, Leblanc E, Manson JE, Feldman D, Linos E,

et al. Calcium plus vitamin D sup-plementation and the

risk of nonmelanoma and melanoma skin cancer: post

hoc analyses of the Women’s Health Initiative Randomized

Controlled Trial. J Clin Oncol. 2011; 29:3078-84.

Kavitha K, Reddy. The role of vitamin D in melanoma

prevention: Evidence and hyperbole. J Am Acad Dermatol.

; 71:1005.

Major JM, Kiruthu C, Weinstein SJ, Horst RL, Syder K, Virtamo

J, et al. Pre-diagnostic circulating vitamin D and risk

of melanoma in men. PLoS ONE. 2012; 7, e35112.

Mason RS, Sequeira VB, Dixon KM, Gordon-Thomson

C, Pobre K, Dilley A, et al. Photoprotection by 1alpha,

-dihydroxyvitamin D and analogs: Further studies on

mechanisms and implications for UV-damage. J Steroid

Biochem Mol Biol. 2010; 121:164-8.

Dixon KM, Deo SS, Norman AW, Bishop JE, Halliday GM,

Reeve VE, et al. In vivo relevance for photoprotection by

the vitamin D rapid response pathway. J Steroid Biochem

Mol Biol. 2007; 103:451-6.

Nurnberg B, Graber S, Gartner B, Geisel J, Pfohler C,

Schadendorf D, et al. Reduced serum 25-hydroxyvitamin

D levels in stage IV melanoma patients. Anticancer Res.

; 29: 3669-74.

Rosso S, Sera F, Segnan N, Zanetti R. Sun exposure prior

to diagnosis is associated with im-proved survival in melanoma

patients: results from a long-term follow-up study

of Italian pa-tients. Eur J Cancer. 2008; 44:1275-81.

Shipman AR, Clark AB, Levell NJ. Sunnier European countries

have lower melanoma mortality. Clin Exp Dermatol.

; 36:544-7.

Gandini S, De Vries E, Tosti G, Botteri E, Spadola G, Maisonneuve

P, et al. Sunny holidays be-fore and after melanoma

diagnosis are respectively associated with lower

breslow thickness and lower relapse rates in Italy. PLoS

ONE. 2013; 8:e78820.

Gandini S, Montella M, Ayala F, Benedetto L, Rossi CR,

Vecchiato A, et al. Sun exposure and melanoma prognostic

factors. Oncol Lett. 2016; 11:2706-14.

Institute of Medicine, Food and Nutrition Board. Dietary

reference intakes for calcium and vit-amin D. Washington:

National Academic Press; 2010.

Ovesen L, Brot C, Jakobsen J. Food contents and biological

activity of 25-hydroxyvitamin D: a vitamin D metabolite

to be reckoned with? Ann Nutr Metab. 2003;

:107-13.

Dawson-Hughes B, Mithal A, BonjourJP, Boonen S, Burckhardt

P, Fuleihan GE, et al. IOF posi-tion statement:

vitamin D recommendations for older adults. Osteoporos

Int. 2010; 21:1151-4.